Collegium Pharmaceutical, Inc.COLLNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+7.6%
5Y CAGR+19.5%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+7.6%/yr
vs +11.3%/yr prior
5Y CAGR
+19.5%/yr
Recent deceleration
Acceleration
-3.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $317.31M | +24.9% |
| 2024 | $254.10M | +5.6% |
| 2023 | $240.60M | -5.4% |
| 2022 | $254.44M | +101.5% |
| 2021 | $126.25M | -3.0% |
| 2020 | $130.18M | -32.8% |
| 2019 | $193.66M | +16.9% |
| 2018 | $165.68M | +6284.5% |
| 2017 | $2.60M | +1118.3% |
| 2016 | $213000.00 | - |